Atossa Genetics Inc Stock
Price
Target price
€0.70
€0.70
1.130%
0.008
1.130%
€6.42
04.07.25 / Tradegate
WKN: A2JJ99 / Symbol: ATOS / Name: Atossa Genetics / Stock / Healthcare Equipment & Supplies / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
Atossa Genetics Inc Stock
Atossa Genetics Inc gained 1.130% today.
We see a rather positive sentiment for Atossa Genetics Inc with 12 Buy predictions and 1 Sell predictions.
Based on the current price of 0.7 € the target price of 6 € shows a potential of 755.92% for Atossa Genetics Inc which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Atossa Genetics Inc stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Atossa Genetics Inc in the next few years
Pros
?
S********** s********
?
M***** P*******
?
B****
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Atossa Genetics Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Atossa Genetics Inc | 1.130% | -8.246% | -6.283% | -33.868% | -27.433% | -27.977% | -79.193% |
| Aortech International plc | 0.970% | -3.704% | 4.523% | 15.556% | -7.143% | -73.869% | -91.875% |
| Theralase Technologies Inc | 2.830% | 6.863% | 0.926% | -6.034% | -31.875% | -49.065% | -22.695% |
| Medmira Inc. | 2.410% | -1.163% | -3.409% | -13.265% | -46.875% | -50.000% | - |
Comments
Atossa Therapeutics, Inc. (NASDAQ: ATOS) had its price target raised by analysts at Ascendiant Capital Markets from $7.25 to $7.50. They now have a "buy" rating on the stock.
Show more
Ratings data for ATOS provided by MarketBeat
Atossa Therapeutics, Inc. (NASDAQ: ATOS) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $4.00 price target on the stock.
Show more
Ratings data for ATOS provided by MarketBeat
Atossa Therapeutics, Inc. (NASDAQ: ATOS) had its price target raised by analysts at Ascendiant Capital Markets from $7.00 to $7.25. They now have a "buy" rating on the stock.
Show more
Ratings data for ATOS provided by MarketBeat